Duck Virus Enteritis (Duck Plague): Clinical Signs and Diagnosis

What Is Ducks Disease? Defining Duck Virus Enteritis

Duck virus enteritis (DVE), also known as duck plague, is a highly contagious and often fatal viral disease affecting waterfowl. The causative agent is a herpesvirus classified as Anatid herpesvirus 1 (AnHV-1) within the family Herpesviridae, subfamily Alphaherpesvirinae. The disease was first recognized in the Netherlands and subsequently identified in many duck-producing regions worldwide. The term "what is ducks disease" frequently refers to this specific viral syndrome, which is characterized by sudden onset, high morbidity, and rapid mortality in susceptible flocks. The virus causes extensive vascular and gastrointestinal damage, leading to characteristic clinical signs and pathological lesions [1, 2, 3].

Etiology and Virological Properties

Virion Structure and Genome

AnHV-1 is an enveloped virus with an icosahedral capsid and a double-stranded DNA genome approximately 150–160 kbp in length. Complete genome sequences of several virulent and vaccine strains have been determined, revealing a typical alphaherpesvirus genomic architecture with unique long (UL) and unique short (US) regions flanked by inverted repeats [2, 4, 3]. The genome encodes numerous structural and nonstructural proteins. The UL24 protein mediates innate immune evasion by initiating K48/K63-linked polyubiquitination of interferon regulatory factor 7 (IRF7) [5]. The US3 protein kinase similarly inhibits DNA sensing through phosphorylation of IRF7 [6]. The UL50 gene product is essential for viral replication and pathogenesis, functioning in nucleotide metabolism [7]. The LORF4 gene is a late gene that is nonessential for in vitro replication but likely contributes to in vivo fitness [8]. The viral protein VP26 interacts with the host actin-myosin II network to facilitate viral proliferation [9].

Variants and Attenuation

Field isolates exhibit variable pathogenicity. A novel variant harboring a deletion in the UL2 gene was characterized and shown to have altered biological properties [4, 10]. Attenuated vaccine strains often possess combined gene deletions that reduce intestinal pathogenicity and restore gut microbiota balance [11]. Marker vaccines with deletions in ICP27 have been constructed for DIVA (differentiating infected from vaccinated animals) purposes [12].

Epidemiology

Host Range and Transmission

DVE primarily affects ducks, geese, and swans within the order Anseriformes. Muscovy ducks (Cairina moschata) and mallards (Anas platyrhynchos) are highly susceptible. The virus can also infect chickens under experimental conditions, though horizontal transmission in chickens is inefficient [13, 14]. Wild waterfowl serve as reservoirs and can introduce virus into domestic flocks. Transmission occurs via the fecal-oral route, through contaminated water, feed, or fomites. The virus can be shed in feces and oropharyngeal secretions for several weeks after infection. Vertical transmission is not well documented but remains a theoretical concern given the herpesvirus latency characteristics [1, 15].

Geographic Distribution

DVE has been reported in Asia, Europe, North America, and Africa. Outbreaks continue to occur even in vaccinated flocks due to the emergence of variant strains or insufficient vaccine coverage. A virulent strain causing outbreak in vaccinated duck flocks was recently isolated in China [1]. A novel DVEV variant from geese demonstrated altered genomic characteristics and viral shedding patterns [15]. In Bangladesh, a virulent isolate was fully sequenced, underscoring the global distribution of pathogenic strains [2].

Clinical Signs

Incubation Period and Forms of Disease

The incubation period ranges from 3 to 7 days under natural conditions. Disease presentation can be peracute, acute, or chronic. Peracute cases die suddenly without premonitory signs. Acute disease is most common and is characterized by depression, photophobia, anorexia, polydipsia, and ataxia. Serous or hemorrhagic discharge from the nares and eyes is frequently observed. The hallmark clinical sign is a profuse, watery, often blood-tinged diarrhea, leading to rapid dehydration and weight loss [1, 10]. In chronic or recovered birds, emaciation and intermittent diarrhea may persist for weeks.

Ocular and Neurological Signs

Ocular involvement includes conjunctivitis, lacrimation, and in severe cases, corneal opacity or ulceration. Neurological signs such as tremors, opisthotonos, and wing droop have been described in some outbreaks, particularly in ducklings. The degree of neurological involvement is influenced by viral strain and host age [16, 15].

Morbidity and Mortality

Morbidity often reaches 80–100% in naive flocks, with mortality ranging from 5% to 90% depending on age, immune status, and virus virulence. Adult laying ducks may exhibit a precipitous drop in egg production before other clinical signs become apparent. Infected breeders produce eggs with thin shells and poor hatchability [1, 10].

Pathological Findings

Gross Lesions

Necropsy findings are dominated by vascular damage and hemorrhages. The most characteristic lesions include hemorrhagic rings and petechiae on the mucosa of the esophagus, pharynx, and intestine. The esophagus and cloaca often contain diphtheritic membranes or pseudomembranes composed of fibrin and necrotic debris. The liver is enlarged, friable, and may exhibit pale, necrotic foci. The spleen is often mottled with hemorrhage or necrosis. Hemorrhages are also found on the heart, gizzard, and in the abdominal fat. The bursa of Fabricius is frequently atrophied or hemorrhagic [1, 10, 15].

Histopathology

Microscopic examination reveals extensive necrosis of epithelial cells in gastrointestinal mucosa, with intranuclear inclusion bodies (Cowdry type A) characteristic of herpesvirus infection. The liver displays multifocal hepatocyte necrosis and periportal lymphocytic infiltration. Lymphoid organs show depletion of lymphocytes and necrosis of germinal centers. Vascular endothelial damage results in fibrinoid necrosis and thrombosis, explaining the hemorrhagic diathesis [16, 10].

Diagnosis

Differential Diagnosis

The clinical signs and lesions of DVE overlap with several other waterfowl diseases, making laboratory confirmation essential. Important differentials include:

A systematic approach to rule out these pathogens using laboratory techniques is recommended [1, 17, 18].

Laboratory Diagnostic Techniques

Virus Isolation

Isolation of AnHV-1 is performed in embryonated duck eggs (or chicken eggs adapted strains) and primary duck embryo fibroblasts (DEF) or chicken embryo fibroblasts (CEF). Cytopathic effect characterized by rounding, syncytia formation, and intranuclear inclusion bodies develops within 48–72 hours. Virus isolation is considered the gold standard but is time-consuming and requires biosafety level 2 facilities [1, 19].

Molecular Detection

Polymerase chain reaction (PCR) has become the primary diagnostic tool for rapid detection of DVE. Conventional PCR targeting conserved regions of the UL or US genes is widely used. Real-time quantitative PCR (qPCR) offers increased sensitivity and quantification. Multiplex PCR assays have been developed to simultaneously detect DVE, goose parvovirus, and Muscovy duck parvovirus [17]. A recombinase polymerase amplification (RPA) assay using real-time fluorescence provides rapid detection within 15–20 minutes with minimal instrumentation [20]. The multienzyme isothermal rapid amplification (MIRA) platform has been employed to develop MIRA-qPCR and MIRA-lateral flow dipstick (LFD) assays, enabling point-of-care detection [21]. Visual gene chip technology allows simultaneous detection of seven waterfowl viral pathogens, including DVE, on a single platform [18].

Serology

Serological diagnosis detects antibodies against AnHV-1 using virus neutralization (VN), enzyme-linked immunosorbent assay (ELISA), or indirect immunofluorescence. VN is specific but labor-intensive. Commercial ELISA kits for DVE are available but may vary in sensitivity. Serology is useful for surveillance and vaccine response evaluation, though it cannot differentiate infected from vaccinated animals unless marker vaccines are used [12].

Novel Emerging Technologies

CRISPR/Cas9-mediated editing has been employed for constructing recombinant vaccines and for potentially developing diagnostic probes [22]. Proteomic and untargeted metabolomic approaches have identified host targets and metabolic alterations during infection, which may lead to biomarker-based diagnostics [9, 23]. RNA sequencing (RNA-seq) has been used to investigate chlorogenic acid intervention in infected duck embryo fibroblasts, revealing transcriptomic changes that could inform diagnostic signatures [24]. Genomic characterization tools including infectious bacterial artificial chromosome (BAC) cloning allow detailed analysis of virulence determinants [3].

Diagnostic Workflow

A structured diagnostic algorithm is presented below.

flowchart TD
    A[Suspected DVE outbreak], > B[Clinical examination and history]
    B, > C{Typical signs? <br> High mortality, hemorrhagic diarrhea, <br> ocular discharge}
    C, >|Yes| D[Necropsy and gross lesion assessment]
    C, >|No| E[Consider other differentials]
    D, > F{Characteristic lesions? <br> Esophageal pseudomembranes, <br> hemorrhagic enteritis, <br> liver necrosis}
    F, >|Yes| G[Sample collection: liver, spleen, <br> esophagus, cloacal swabs]
    F, >|No| E
    G, > H{Diagnostic method}
    H, > I[Virus isolation in DEF/eggs]
    H, > J[Molecular: PCR, qPCR, RPA, MIRA]
    H, > K[Histopathology: intranuclear inclusions]
    I, > L[Confirmation by immunofluorescence or PCR]
    J, > M[Positive for AnHV-1 DNA]
    K, > N[Positive for Cowdry type A inclusions]
    L, > O[Definitive DVE diagnosis]
    M, > O
    N, > O
    E, > P[Rule out other pathogens]

Treatment and Control

Antiviral Strategies

No licensed antiviral drug is specifically approved for DVE. Piperazine derivatives were shown to inhibit AnHV-1 infection in vitro by modulating host cytokine responses, suggesting a potential therapeutic avenue [25]. Poly I:C (polyinosinic-polycytidylic acid) alleviated intestinal injury in infected ducks by inhibiting apoptosis, indicating that immunomodulators may reduce pathology [26]. These findings remain experimental.

Vaccination

Vaccination is the cornerstone of DVE prevention. Live attenuated vaccines derived from serial passage in chicken embryo fibroblasts or duck embryos are widely used. An Indian strain-based live attenuated vaccine developed in chicken embryo fibroblast cell culture demonstrated safety and efficacy [19]. Recombinant vector vaccines have been constructed to express immunogenic proteins from duck hepatitis A virus, duck Tembusu virus, goose astrovirus, and influenza virus, providing multivalent protection [27, 28, 29, 30, 31, 32]. A recombinant DVE virus expressing the OmpH gene of Pasteurella multocida simultaneously protects against duck plague and fowl cholera [33]. Marker vaccines with deleted virulence genes allow serological differentiation [12]. However, vaccine breaks due to variant strains necessitate continuous surveillance and vaccine strain updates [1].

Biosecurity and Control Measures

Control relies on strict biosecurity: quarantine of new birds, disinfection of equipment, and avoidance of contact with wild waterfowl. The virus is susceptible to lipid solvents, formaldehyde, and sodium hypochlorite. In an outbreak, depopulation of affected flocks and thorough cleaning and disinfection are required. Movement restrictions on live birds and eggs should be enforced. Vaccination of at-risk flocks is recommended in endemic areas.

Conclusions

Duck virus enteritis remains a major threat to domestic and wild waterfowl populations worldwide. The clinical presentation and pathological features are largely consistent across strains, but variant viruses with altered virulence and genomic deletions are emerging [4, 10]. Diagnosis increasingly relies on rapid molecular techniques such as RPA and MIRA, which offer field-deployable options [20, 21]. Continued research into viral pathogenesis, immune evasion mechanisms, and recombinant vaccine development is essential for improved control [7, 9, 5, 6]. Understanding "what is ducks disease" in the veterinary context requires recognition of DVE as a distinct herpesviral entity with characteristic clinical signs, reliable diagnostic methods, and effective but evolving vaccination strategies.

References

[1] Sang S, Wang H, Dan Y et al. Isolation, identification and pathogenicity analysis of a virulent duck enteritis virus strain causing outbreak in vaccinated duck flocks. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42322961/

[2] Yasmin L, Siddique MS, Islam T et al. Complete genome sequence of a virulent duck enteritis virus isolated from Northern part of Bangladesh. Microbiol Resour Announc. 2025. https://pubmed.ncbi.nlm.nih.gov/41134219/

[3] Huo SX, Zhu YC, Chen L et al. Complete Genome Sequence and Construction of an Infectious Bacterial Artificial Chromosome Clone of a Virulent Duck Enteritis Virus Strain XJ. Transbound Emerg Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/40303036/

[4] Yang H, Zhang B, Yang X et al. Complete genome sequence and biological characteristics of a novel duck enteritis virus variant with a deletion in UL2. Arch Virol. 2025. https://pubmed.ncbi.nlm.nih.gov/40991013/

[5] Ruan P, Chen Y, Wang M et al. Duck plague virus UL24 protein initiates K48/K63-linked IRF7 polyubiquitination to antagonize the innate immune response. Poult Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39418790/

[6] Liu R, Gao L, Yang F et al. Duck Enteritis Virus Protein Kinase US3 Inhibits DNA Sensing Signaling by Phosphorylating Interferon Regulatory Factor 7. Microbiol Spectr. 2022. https://pubmed.ncbi.nlm.nih.gov/36287016/

[7] Huo SX, Chen L, Bao ED et al. Functional characterization of UL50 gene reveals its essential role in duck enteritis virus replication and pathogenesis. Vet Q. 2026. https://pubmed.ncbi.nlm.nih.gov/41876382/

[8] Huang J, Wang M, Cheng A et al. Duck enteritis virus LORF4 gene is a late gene and nonessential for virus replication in vitro. Poult Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39288717/

[9] Chen L, Zhu YC, Yun T et al. Proteomic Screening for Cellular Targets of the Duck Enteritis Virus Protein VP26 Reveals That the Host Actin-Myosin II Network Regulates the Proliferation of the Virus. Int J Mol Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41009665/

[10] Yin D, Gao Y, Xu M et al. Pathogenic mechanisms and molecular features of a novel UL2 gene-deficient duck enteritis virus endemic to China. Virulence. 2025. https://pubmed.ncbi.nlm.nih.gov/40801158/

[11] Kong J, Han C, Shao G et al. Virulence attenuation of intestinal pathogenicity via combined gene deletion in duck enteritis vaccine strain restores gut microbiota balance and enhances safety. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41764962/

[12] Wu Y, Liu L, Zhang M et al. A Recombinant Duck Plague Virus Containing the ICP27 Deletion Marker Provides Robust Protection in Ducks. Microbiol Spectr. 2023. https://pubmed.ncbi.nlm.nih.gov/37404171/

[13] Abdulrahim Y, You Y, Wang L et al. Correction: Abdulrahim et al. Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken. Viruses 2024, 16, 1681. Viruses. 2024. https://pubmed.ncbi.nlm.nih.gov/39772278/

[14] Abdulrahim Y, You Y, Wang L et al. Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken. Viruses. 2024. https://pubmed.ncbi.nlm.nih.gov/39599796/

[15] Guo Z, Zhang S, Sun Y et al. Genomic characteristics, pathogenicity and viral shedding of a novel DVEV variant derived from goose. Poult Sci. 2023. https://pubmed.ncbi.nlm.nih.gov/36745957/

[16] Shi X, Zhuang H, Shuo D et al. Pathogenicity Evaluation and Virulence Gene Identification of an Attenuated Duck Enteritis Virus. Microorganisms. 2025. https://pubmed.ncbi.nlm.nih.gov/41304222/

[17] Qiu Q, Hu R, Liu Z et al. Development of a Multiplex Quantitative Polymerase Chain Reaction Assay for the Detection of Duck Enteritis Virus, Goose Parvovirus, and Muscovy Duck Parvovirus. Animals (Basel). 2025. https://pubmed.ncbi.nlm.nih.gov/40509065/

[18] Yan L, Song Y, Zhai T et al. Establishment of a Visual Gene Chip Method for the Simultaneous Detection of Seven Waterfowl Virus Pathogens. Viruses. 2025. https://pubmed.ncbi.nlm.nih.gov/40143287/

[19] Dandapat S, Bindu S, Sharma GK et al. Development and evaluation of a chicken embryo fibroblast cell culture based live attenuated Indian strain duck plague vaccine. Vet Q. 2024. https://pubmed.ncbi.nlm.nih.gov/38726839/

[20] Wan J, Zhu Y, Xu X et al. [Development of a rapid detection method for a virulent strain of duck enteritis virus based on real-time fluorescence recombinase polymerase amplification]. Sheng Wu Gong Cheng Xue Bao. 2026. https://pubmed.ncbi.nlm.nih.gov/42009547/

[21] Dai Y, Hu X, Zhong Y et al. Rapid Detection of Duck Enteritis Virus with MIRA, MIRA-qPCR, and MIRA-LFD Assays. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41156591/

[22] Liu J, Wang Y, Tang N et al. CRISPR/Cas9-edited duck enteritis virus expressing Pmp17G of Chlamydia psittaci induced protective immunity in ducklings. Pathog Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/39400699/

[23] Cai H, Yang X, Yang Y et al. Untargeted metabolomics of the intestinal tract of DEV-infected ducks. Virol J. 2023. https://pubmed.ncbi.nlm.nih.gov/38115106/

[24] Yang Y, Zhang Q, Cai H et al. RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus. Virol J. 2024. https://pubmed.ncbi.nlm.nih.gov/38454409/

[25] Bhattacharya S, Kumar S. Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines. Microb Pathog. 2025. https://pubmed.ncbi.nlm.nih.gov/40484049/

[26] Zhang Y, Wu Y, Zhang X et al. Poly I: C Alleviated Duck Intestinal Injury Infected with Duck Viral Enteritis by Inhibiting Apoptosis. Curr Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/39105989/

[27] Jia W, Wang A, Wu Z et al. Construction and characterization of recombinant duck enteritis virus expressing duck hepatitis A virus 3 immunogenic genes. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41850054/

[28] Zhao Y, Ma Q, Jiao C et al. Recombinant duck enteritis virus harboring the hemagglutinin genes of influenza virus rapidly induces specific cellular immunity in ducks. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/41467842/

[29] Wang L, Yang X, Zhang B et al. Construction and evaluation of a recombinant duck enteritis virus expressing the envelope protein of duck Tembusu virus in ducks. Arch Virol. 2025. https://pubmed.ncbi.nlm.nih.gov/40495073/

[30] Chen L, Zhu Y, Yun T et al. In vitro expression of the goose astrovirus Cap protein delivered with a duck enteritis virus vector. BMC Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/40317044/

[31] Jia WF, Wang AP, Wu Z et al. Current status of recombinant duck enteritis virus vector vaccine research. Front Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/39974164/

[32] Zhao Y, Chen P, Hu Y et al. Recombinant duck enteritis virus bearing the hemagglutinin genes of H5 and H7 influenza viruses is an ideal multivalent live vaccine in ducks. Emerg Microbes Infect. 2024. https://pubmed.ncbi.nlm.nih.gov/37966272/

[33] Apinda N, Muenthaisong A, Chomjit P et al. Simultaneous Protective Immune Responses of Ducks against Duck Plague and Fowl Cholera by Recombinant Duck Enteritis Virus Vector Expressing Pasteurella multocida OmpH Gene. Vaccines (Basel). 2022. https://pubmed.ncbi.nlm.nih.gov/36016245/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[34] Gao L, Liu R, Yang F et al. Duck Enteritis Virus Inhibits the cGAS-STING DNA-Sensing Pathway To Evade the Innate Immune Response. J Virol. 2022. https://pubmed.ncbi.nlm.nih.gov/36448809/

[35] Kong J, Feng K, Zhao Q et al. Pathogenicity and transmissibility studies on live attenuated duck enteritis virus vaccine in non-target species. Front Microbiol. 2022. https://pubmed.ncbi.nlm.nih.gov/36439841/